Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.72 USD | -2.12% | -5.35% | -34.06% |
Mar. 28 | Oppenheimer Initiates Coverage on Immunovant With Outperform Rating, $50 Price Target | MT |
Mar. 13 | Goldman Sachs Starts Coverage on Immunovant With Buy Rating, $50 Price Target | MT |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | 14.41M | Capitalization | 4.11B |
---|---|---|---|---|---|
Net income 2024 * | -250M | Net income 2025 * | -276M | EV / Sales 2024 * | - |
Net cash position 2024 * | 653M | Net cash position 2025 * | 532M | EV / Sales 2025 * | 249 x |
P/E ratio 2024 * |
-15.9
x | P/E ratio 2025 * |
-15.5
x | Employees | 164 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 42.85% |
Latest transcript on Immunovant, Inc.
1 day | -0.39% | ||
1 week | -7.81% | ||
Current month | -12.35% | ||
1 month | -6.44% | ||
3 months | -30.14% | ||
6 months | -23.36% | ||
Current year | -32.78% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Salzmann
CEO | Chief Executive Officer | 56 | 19-05-31 |
Eva Barnett
DFI | Director of Finance/CFO | 44 | 21-10-03 |
Sheetal Patel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
George Migausky
BRD | Director/Board Member | 69 | 19-12-17 |
Andrew Fromkin
BRD | Director/Board Member | 58 | 19-12-17 |
Douglas Hughes
BRD | Director/Board Member | 62 | 19-12-17 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.09% | 0 M€ | 0.00% | - | |
0.04% | 2 M€ | -.--% | ||
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 27.75 | -2.01% | 466 390 |
24-04-18 | 28.32 | -0.39% | 1,227,362 |
24-04-17 | 28.43 | -6.48% | 1,805,188 |
24-04-16 | 30.4 | -0.23% | 970,050 |
24-04-15 | 30.47 | +3.82% | 1,199,779 |
Delayed Quote Nasdaq, April 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.78% | 4.11B | |
-1.82% | 41.35B | |
+42.04% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- IMVT Stock